Edition:
United States

Protalix Biotherapeutics Inc (PLX)

PLX on American Stock Exchange

1.06USD
21 Feb 2017
Change (% chg)

$-0.02 (-1.85%)
Prev Close
$1.08
Open
$1.13
Day's High
$1.14
Day's Low
$1.04
Volume
2,549,677
Avg. Vol
2,711,735
52-wk High
$1.48
52-wk Low
$0.26

PLX

Chart for PLX

About

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). The Company has developed taliglucerase alfa (marketed under the name Uplyso in Brazil and certain other... (more)

Overall

Beta: 0.65
Market Cap(Mil.): ₪387.67
Shares Outstanding(Mil.): 99.93
Dividend: --
Yield (%): --

Financials

  PLX Industry Sector
P/E (TTM): -- 46.79 29.35
EPS (TTM): -1.31 -- --
ROI: -72.58 -3.72 12.97
ROE: -- 4.91 14.11

More From Around the Web

Earnings vs. Estimates